Vivos Therapeuticsinc Stock Profit Margin
| VVOS Stock | USD 2.57 0.08 3.02% |
Vivos TherapeuticsInc fundamentals help investors to digest information that contributes to Vivos TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Vivos Stock. The fundamental analysis module provides a way to measure Vivos TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vivos TherapeuticsInc stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (0.98) | (1.03) |
Vivos | Profit Margin |
Vivos TherapeuticsInc Company Profit Margin Analysis
Vivos TherapeuticsInc's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Vivos TherapeuticsInc Profit Margin | (0.98) % |
Most of Vivos TherapeuticsInc's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vivos TherapeuticsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vivos Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Vivos TherapeuticsInc is extremely important. It helps to project a fair market value of Vivos Stock properly, considering its historical fundamentals such as Profit Margin. Since Vivos TherapeuticsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vivos TherapeuticsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vivos TherapeuticsInc's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Vivos Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Vivos TherapeuticsInc has a Profit Margin of -0.9842%. This is 91.22% lower than that of the Health Care Equipment & Supplies sector and 81.97% lower than that of the Health Care industry. The profit margin for all United States stocks is 22.5% lower than that of the firm.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Vivos Fundamentals
| Return On Equity | -5.21 | ||||
| Return On Asset | -0.88 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (1.27) % | ||||
| Current Valuation | 7.59 M | ||||
| Shares Outstanding | 2.98 M | ||||
| Shares Owned By Insiders | 7.30 % | ||||
| Shares Owned By Institutions | 13.73 % | ||||
| Number Of Shares Shorted | 18.69 K | ||||
| Price To Book | 18.94 X | ||||
| Price To Sales | 0.57 X | ||||
| Revenue | 13.8 M | ||||
| Gross Profit | 12.6 M | ||||
| EBITDA | (16.68 M) | ||||
| Net Income | (13.58 M) | ||||
| Cash And Equivalents | 17.83 M | ||||
| Cash Per Share | 0.77 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 3.15 X | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | (11.95 M) | ||||
| Short Ratio | 0.24 X | ||||
| Earnings Per Share | (11.14) X | ||||
| Target Price | 7.22 | ||||
| Number Of Employees | 114 | ||||
| Beta | 7.9 | ||||
| Market Capitalization | 7.9 M | ||||
| Total Asset | 10.73 M | ||||
| Retained Earnings | (93.05 M) | ||||
| Working Capital | (4.83 M) | ||||
| Net Asset | 10.73 M |
About Vivos TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vivos TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivos TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivos TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vivos TherapeuticsInc is a strong investment it is important to analyze Vivos TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vivos TherapeuticsInc's future performance. For an informed investment choice regarding Vivos Stock, refer to the following important reports:Check out Vivos TherapeuticsInc Piotroski F Score and Vivos TherapeuticsInc Altman Z Score analysis. For more information on how to buy Vivos Stock please use our How to Invest in Vivos TherapeuticsInc guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Vivos Stock analysis
When running Vivos TherapeuticsInc's price analysis, check to measure Vivos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos TherapeuticsInc is operating at the current time. Most of Vivos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Vivos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Vivos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Vivos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos TherapeuticsInc. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.14) | Revenue Per Share 11.318 | Quarterly Revenue Growth (0.18) | Return On Assets (0.88) | Return On Equity (5.21) |
The market value of Vivos TherapeuticsInc is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Vivos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Vivos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.